Informa Pharma Intelligence has announced Citeline Engage, a new solution allowing contact research organizations (CROs) and sponsors to optimize site selection and increase trial efficiencies to accelerate clinical trial timelines and enable a faster path to market for drugs. Citeline Engage is a solution designed specifically to help optimize protocol development, site feasibility, and most importantly, increase physician engagement and drive patient awareness to support faster enrollment into clinical trials.
Clinical trials have long been a pain point for industry players, and Citeline Engage is designed to help increase efficiency across a notoriously difficult, yet imperative area, of the pharma industry. Informa Pharma Intelligence’s Citeline Engage utilizes real-world data to offer the most efficient outreach services that allow customers to better recruit investigators and patients, optimize trial protocols, and ignite awareness around trials.
By combining trial and investigator intelligence available through Citeline with a verified audience of healthcare professionals through Skipta, Citeline Engage helps CROs and sponsors expedite patient enrollment, drive efficiency and mitigate the risk of trial failure:
“We have the real-world data to create powerful connections and optimize protocol development, site feasibility, and most importantly physician engagement and patient awareness,” said Nicola Marlin, Vice President of Product Development at Informa Pharma Intelligence. “Citeline Engage empowers organizations to create and run the most efficient clinical trials possible through targeting and recruiting top tier investigators and select sites using online communities of verified healthcare professionals.”
Including Women of Childbearing Age in Clinical Research
March 26th 2024In recognition of International Women's Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and Marie Teil, Global Head of UCB’s Women of Childbearing Age Program. They speak about the specific challenges women with chronic illnesses face when accessing appropriate treatment and participating in clinical trials, UCB's Women of Childbearing Age Program and it’s most successful strategies, and much more.
Improving Engagement While Maintaining Data Integrity & Validity
March 19th 2024In recognition of Women's Health Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and uMotif's Chief Product Officer, Julia Lakeland, discuss new technologies improving patient engagement and reducing the emotional and logistical burdens of participation, ethical considerations that should be addressed when implementing those technologies, while ensuring patient privacy, and much more.